JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, cilt.26, sa.11, ss.1622-1629, 2015 (SCI-Expanded)
Purpose: To compare doxorubicin-loaded HepaSphere transarterial chemoembolization versus conventional transarterial chemoembolization in terms of survival, time to recurrence, acute reversible hepatotoxicity, postembolization syndrome, and chemoembolization-related mortality and morbidity.